AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

What is the impact on the domestic Pharmaceutical industry? Many listed companies respond to the USA's tariff on Pharmaceutical.

① Most surveyed listed Pharmaceutical companies are not panicking. Some companies state that if Pharmaceutical tariffs are implemented, they will raise prices to ensure product gross margin; ② Other companies mention that their products are difficult to substitute in the U.S. and are closely monitoring related developments; ③ Industry experts state that if Pharmaceutical tariffs are implemented, compared to Active Pharmaceutical Ingredients and generic drugs, Innovative Drugs may be the least impacted.

cls.cnApr 9 05:24 ET

Trending Industry Today: PHARMARON Leads Losses In CRO Stocks

Moomoo NewsApr 8 23:10 ET

Strong policies to maintain stability inject confidence, the Agriculture chain and CSI Consumer 360 index are expected to progress together.

Track the entire lifecycle of the main Sector.

cls.cnApr 8 21:28 ET

The U.S. tariff policy will not affect overseas clients signing contracts. Joinn Laboratories: Focus on the expansion of offshore outsourcing Business | Directly covering the Earnings Conference.

In the Earnings Conference, Joinn Laboratories stated that due to reasons such as the services provided by the company not falling within the scope of tariff implications, the USA's tariff policy will not affect the signing of overseas customer Orders. The company's CFO answered questions regarding the reasons for the decline in overseas Business revenue and gross margin in 2024, as well as the company's Operation plans for 2025.

cls.cnApr 7 09:21 ET

The "Global stock market shock" surged to the top of the hot search, the 300ETF experienced a trading volume of 27 billion, and public offerings suggest: act more cautiously.

① After the sharp decline in US stocks, Asia-Pacific followed suit, with "the search for stock market turbulence" trending at number one; ② The trading volume of broad-based ETFs expanded, with four 300ETFs surpassing 27 billion in trading volume; ③ QDII-ETFs are showcasing the "disappearance of premiums", as high premiums still carry risks; ④ Long-term government bonds have become a refuge for capital.

cls.cnApr 7 02:03 ET